Drug purchases under the 340B program totaled $53.7 billion in 2022, or 22.3% more than the $43.9 billion in 2021, [...] …
Month: September 2023
Hospital 340B covered entity and child sites increased by more than 400% over the last 11 years, while the number [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Amid an increasing number of drugmaker restrictions and requirements on the use of contract pharmacies, 340B providers are trying a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program could more than double in size if the 340B patient definition expands, according to a recent report [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Senate committee rejected an effort to add new 340B hospital verification requirements as part of a sweeping healthcare funding [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Attorneys representing Arkansas and 340B providers sparred with a drug industry lawyer over the constitutionality of Arkansas’ first-in-the-nation 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Teva Pharmaceuticals this week ended its 340B contract pharmacy restrictions in Arkansas in response to a state law that prevents [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Located in rural Peterborough, New Hampshire, Monadnock Community Hospital (MCH) is a critical access hospital that offers comprehensive inpatient and outpatient services and is celebrating its 100th anniversary. MCH joined a Signify Health Accountable Care Organization (ACO) in 2023 to align with
…
Drug manufacturer Incyte Corp. this week announced it will become the 26th drug manufacturer to restrict access to 340B pricing when [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Nearly one-quarter of the 200 provider audits planned for this year were closed by regulators with no adverse findings, they [...] …
